![](https://cdn.benzinga.com/files/images/story/2024/07/16/Ozempic-maker-Novo-Nordisk.jpeg?width=1200&height=800&fit=crop)
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
Democratic U.S. Senate aides will meet with executives from Novo Nordisk A/S NVO on Tuesday to discuss the ramifications of the company’s decision to cease selling its long-acting insulin Levemir in the U.S. by the end of 2024. Senators Jeanne Shaheen, …